{"filing":{"accession_number":"0001193125-26-234440","cik":"0001756262","ticker":"TMDX","company_name":"TransMedics Group, Inc.","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"d79022d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1756262/000119312526234440/d79022d8k.htm"},"events":[{"id":9407,"run_id":8247,"accession_number":"0001193125-26-234440","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure reports the results of TransMedics' 2026 Annual Meeting of Shareholders held on May 20, 2026, including voting outcomes on four proposals: election of eight directors, advisory approval of named executive officer compensation, amendment to the 2019 Stock Incentive Plan, and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies for each proposal are material to shareholders' understanding of governance and corporate direction.","company_name":"TransMedics Group, Inc.","ticker":"TMDX","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":1033,"accession_number":"0001193125-26-234440","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of TransMedics' 2026 Annual Meeting of Shareholders held on May 20, 2026, including voting outcomes on four proposals: election of eight directors, advisory approval of named executive officer compensation, amendment to the 2019 Stock Incentive Plan, and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies for each proposal are material to shareholders' understanding of governance and corporate direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:38:12.593204+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1033,"accession_number":"0001193125-26-234440","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of TransMedics' 2026 Annual Meeting of Shareholders held on May 20, 2026, including voting outcomes on four proposals: election of eight directors, advisory approval of named executive officer compensation, amendment to the 2019 Stock Incentive Plan, and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies for each proposal are material to shareholders' understanding of governance and corporate direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:38:12.593204+00:00","company_name":"TransMedics Group, Inc.","ticker":"TMDX","filing_date":"2026-05-21"}]}